# Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

> **NCT03830164** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 14 (actual)

## Conditions studied

- Male Erectile Disorder
- Prostate Adenocarcinoma
- Erectile Dysfunction, CTCAE
- Impotence

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Pentoxifylline
- **DIETARY_SUPPLEMENT:** Vitamin E Compound

## Key facts

- **NCT ID:** NCT03830164
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-20
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03830164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03830164, "Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03830164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*